US$12 Billion RNA Deal Triggers Sector Shakeup
Source: Streetwise Reports (11/14/2025)
Avidity Biosciences Inc. (RNA:NASDAQ) reported Q3 results alongside news of its US$12 billion acquisition by Novartis. The deal comes as three RNA drugs approach major regulatory filings through 2026.
read more >
Silver, Copper Now Critical Metals in US
Source: Streetwise Reports (11/14/2025)
This new designation is expected to boost these two segments of the mining industry in the U.S. and potentially allied countries. Keep reading to learn more about three companies that could benefit: Regency Silver Corp. (RSMX:TSX.V; RSMXF:OTCQB), Dolly Varden Silver Corp. (DV:TSX.V; DVS:NYSEA; DVQ:FSE) and Silver North Resources Ltd. (SNAG:TSX.V; TARSF:OTCQB).
read more >
Lead Drug Faces Uncertain FDA Path After Phase 3 Miss
Source: Streetwise Reports (11/13/2025)
aTyr Pharma Inc. (ATYR:NASDAQ) is seeking regulatory clarity following mixed Phase 3 results for its lead candidate efzofitimod in pulmonary sarcoidosis. The company expects feedback from the FDA in the first quarter of 2026 to help determine a potential path forward.
read more >
Explorer Triples Ontario Gold System After Breakthrough 2025 Drilling
Source: Streetwise Reports (11/13/2025)
Dryden Gold Corp. (DRY:TSXV; DRYGF:OTCQB; FSE: X7W) tripled the strike length of the Elora Gold System to over 800 meters during its 2025 drill program. The company also reported new gold-bearing structures and key intercepts across multiple zones at Gold Rock Camp.
read more >
Silver Co. Extends High-Grade Gold Deposit in Golden Triangle
Source: Streetwise Reports (11/13/2025)
Dolly Varden Silver Corp. (DV:TSX.V; DVS:NYSEA; DVQ:FSE) announces drilling results that expand the high-grade gold zone within the Homestake Silver deposit, 26.74 grams per tonne gold (g/t Au) over 14.75 meters, including 122 g/t Au over 2.85 meters.
read more >